This study is testing a drug called Gleolan that makes ovarian cancer tumors glow under blue light during surgery. The goal is to help surgeons see and remove more cancerous tissue than they can with standard methods alone. The trial will involve about 170 women with suspected ne…
Phase: PHASE3 • Sponsor: NX Development Corp • Aim: Diagnosis
Last updated Mar 30, 2026 14:34 UTC